SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001615774-19-002511
Filing Date
2019-02-14
Accepted
2019-02-14 15:37:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A s116134_sc13ga.htm SC 13G/A 62840
  Complete submission text file 0001615774-19-002511.txt   64458
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-79594 | Film No.: 19605492
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE SUITE 207 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE SUITE 207 PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A